#osteoporosis baseline lab work should be completed to assess for secondary causes. DEXA is underutilized in men and should be considered especially in men with inflammatory disease Baseline labs: CBC, BMP, PTH, vit D, TSH, urine ca, testosterone #ACR22 @RheumNow https://t.co/byXLQFpe3n

2019 Reccs for #OA RX- educate, exercise and weight mgmt is cornerstone . Hyaluronic acid supplementation and stem cell, PRP injx not recc. #acr22 ⁦#acrreview⁩ @rheumnow https://t.co/v5w84z9eCu

What's the clinical use of imaging in #osteoarthritis? 👉Useful in atypical presentations, NOT required for dx 👉Always consider the view (particularly knees) 👉No evidence in predicting response to non-surgical tx #ACR22 @RheumNow #acrreview https://t.co/nlRI1dbbud

#Exercise does NOT increase the risk for knee replacement but can provide a protective effect - Dr Scanzelloe on #OA @rheumnow #acr22 #acrreview https://t.co/a8Q1FLUvcw

Exciting time to be doing research in GCA! Over half a dozen ongoing RCTs Challenging to recruit enough patients given (1) competing trials (2) reticence to join a trial when tocilizumab (standard of care) is available #ACR22 #Vasculitis22 @RheumNow https://t.co/mJm69gH4N9

❗Encouraging weight loss in #osteoarthritis is really challenging! @rheumarhyme But this slide👇 is reassuring and we can use it to motivate our patients. #ACR22 @rheumnow #acrreview https://t.co/hUa56UfJPA

Short-term intra-articular steroids are effective (unclear- long term benefits) - no increase risk for knee replacement with repeat steroid injx #osteoarthritis @rheumnow #acr22 #acrreview https://t.co/MJHXWePF70

Nice summary slide of the recently published 2022 Classification Criteria for GCA and TAK! Avalable free! TAK: https://t.co/0aMVPvKgyE GCA: https://t.co/s1aiFpq3r2 #ACR22 #Vasculitis22 @RheumNow https://t.co/x9ufxi7aco

• https://onlinelibrary.wiley.com/doi/full/10.1002/art.42324
• https://onlinelibrary.wiley.com/doi/full/10.1002/art.42325

Medicare will cover #DXA testing for these diagnoses ⁦@RheumNow⁩ #acr22 #acrreview https://t.co/keZg0fxyz9

Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years ⁦@RheumNow⁩ #acr22 #acrreview #osteoporosis https://t.co/Xzr6TZIlWN

Drug holidays for #osteoporosis RX but be note fracture risk may increase with these holidays- consider an anabolic agent during these times - Dr Tanner #acr22 ⁦@RheumNow⁩ #acrreview https://t.co/6XbpYD5D1X

Dr Tanner presents the features of AFF👇 It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use. #ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj

P1NP is a useful bone turnover marker that Dr. Tanner checks to monitor #osteoporosis therapy (if insurance covers it) - it is not affected by diurnal variation, food, renal function. #ACR22 @rheumnow #ACRReview

Here's a nice slide comparing Sjogren's disease and Sarcoidosis: #ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f

Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data I personally love this strategy; I think Phase 2's are an expensive waste of time Better to go big and answer the question? COI: I participate in SELECT-GCA #ACR22 @RheumNow #Vasculitis22 https://t.co/fSs3xt8baA